Blog
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates
Generation Bio Co. (GBIO) came out with a quarterly loss of $3.12 per share versus the Zacks Consensus Estimate of a loss of $2.8. This compares to a loss of $3.1 per share a year ago. These figures
Is the Options Market Predicting a Spike in Ashland Stock?
Investors in Ashland Inc. ASH need to pay close attention to the stock based on moves in the options market lately. That is because the Oct. 17, 2025 $40 Callhad some of the highest implied
Surf Air Mobility Inc. (SRFM) Reports Q2 Loss, Beats Revenue Estimates
Surf Air Mobility Inc. (SRFM) came out with a quarterly loss of $0.93 per share versus the Zacks Consensus Estimate of a loss of $1.09. This compares to a loss of $1.96 per share a year ago. These
NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates
NeuroPace, Inc. (NPCE) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.26 per share a year ago. These figures
Theravance Biopharma (TBPH) Reports Q2 Loss, Tops Revenue Estimates
Theravance Biopharma (TBPH) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.13 per share a year ago. These
Luminar Technologies, Inc. (LAZR) Reports Q2 Loss, Lags Revenue Estimates
Luminar Technologies, Inc. (LAZR) came out with a quarterly loss of $1.49 per share versus the Zacks Consensus Estimate of a loss of $1.19. This compares to a loss of $2.7 per share a year ago
GCT Semiconductor Holding, Inc. (GCTS) Reports Q2 Loss, Misses Revenue Estimates
GCT Semiconductor Holding, Inc. (GCTS) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.02 per share a year
Verrica Pharmaceuticals Inc. (VRCA) Q2 Earnings and Revenues Beat Estimates
Verrica Pharmaceuticals Inc. (VRCA) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.7 per share. This compares to a loss of $3.1 per share a
Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates
Absci Corporation (ABSI) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.22 per share a year ago. These
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Beats Revenue Estimates
Lyra Therapeutics, Inc. (LYRA) came out with a quarterly loss of $5.51 per share versus the Zacks Consensus Estimate of a loss of $5.79. This compares to a loss of $14.5 per share a year ago. These
Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates
Editas Medicine (EDIT) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to a loss of $0.82 per share a year ago. These figures
Fate Therapeutics (FATE) Reports Q2 Loss, Beats Revenue Estimates
Fate Therapeutics (FATE) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.33 per share a year ago. These
Intellicheck Mobilisa, Inc. (IDN) Reports Q2 Loss, Tops Revenue Estimates
Intellicheck Mobilisa, Inc. (IDN) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.01 per share a year ago. These figures
Intapp (INTA) Beats Q4 Earnings and Revenue Estimates
Intapp (INTA) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.15 per share a year ago. These figures are
Lumentum (LITE) Q4 Earnings and Revenues Top Estimates
Lumentum (LITE) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.82 per share. This compares to earnings of $0.06 per share a year ago. These figures
Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates
Journey Medical Corporation (DERM) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.17 per share a year ago
Lineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates
Lineage Cell (LCTX) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.03 per share a year ago. These figures are
Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates
Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.2 per share a year ago. These
TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.21 per share a year ago
Stoke Therapeutics, Inc. (STOK) Reports Q2 Loss, Tops Revenue Estimates
Stoke Therapeutics, Inc. (STOK) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of $0.57. This compares to a loss of $0.46 per share a year ago. These
These 3 Companies Shattered Quarterly Records
The 2025 Q2 earnings cycle continues to wind down, with the vast majority of S&P 500 companies already delivering results. The period has been one of resilience, with overall growth remaining strong
Buying the Best Value Stocks as the Market Hits All-Time Highs
The Nasdaq and the S&P 500 surged to new highs on Tuesday as Wall Street ramps up its bets on interest rate cuts after a slightly cooler-than-expected July inflation print.
The other market-moving
Air Lease Shares Up 4.8% Since Q2 Earnings & Revenues Top Estimates
Shares of Air Lease Corporation (AL) have gained 4.8% since its second-quarter 2025 earnings release on Aug. 4, 2025. The uptick can be attributed to the better-than-expected earnings and revenue
Circle Internet Group, Inc. (CRCL) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2025, Circle Internet Group, Inc. (CRCL) reported revenue of $658.08 million, representing no change compared to the same period last year. EPS came in at $1.02, compared
Sea Limited (SE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended June 2025, Sea Limited Sponsored ADR (SE) reported revenue of $5.36 billion, up 37.2% over the same period last year. EPS came in at $0.85, compared to $0.46 in the year-ago


